Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Zachary C. Rosenthal(Harvard University), Stephen J. Haggarty(Harvard University), Gordon C. Werthmann(The University of Texas Southwestern Medical Center), Krista M. Hennig(Harvard University), Jacob M. Hooker(Massachusetts General Hospital), Joachim Herz(Southwestern Medical Center), N. Connor Payne(Harvard University), Rachel Tesla(The University of Texas Southwestern Medical Center), Charlotte Guhl(Friedrich Schiller University Jena), Yueting Chen(Zhejiang University), Ralph Mazitschek(Broad Institute), Daniel M. Fass(Harvard University), Debasis Patnaik(Harvard University), Noelle S. Williams(The University of Texas Southwestern Medical Center), Michael S. Placzek(Harvard University), Xiaoyu Wang(Ministry of Education of the People's Republic of China), Surya A. Reis(Harvard University), Angela She
Scientific Reports
April 20, 2024
Cited by 11


Related Papers